These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32468469)

  • 1. Exosome Biomarkers Revolutionize Preclinical Diagnosis of Neurodegenerative Diseases and Assessment of Treatment Responses in Clinical Trials.
    Kapogiannis D
    Adv Exp Med Biol; 2020; 1195():149. PubMed ID: 32468469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids.
    Vaz M; Soares Martins T; Henriques AG
    J Neurochem; 2022 Nov; 163(4):266-309. PubMed ID: 36156258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases.
    Xia X; Wang Y; Zheng JC
    Transl Neurodegener; 2022 Dec; 11(1):53. PubMed ID: 36510311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges.
    Lee S; Mankhong S; Kang JH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of extracellular vesicles in neurodegenerative diseases.
    Vinaiphat A; Sze SK
    Expert Rev Mol Diagn; 2019 Sep; 19(9):813-824. PubMed ID: 31429341
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases.
    Zanirati G; Dos Santos PG; Alcará AM; Bruzzo F; Ghilardi IM; Wietholter V; Xavier FAC; Gonçalves JIB; Marinowic D; Shetty AK; da Costa JC
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes in bodily fluids are a highly stable resource of disease biomarkers.
    Boukouris S; Mathivanan S
    Proteomics Clin Appl; 2015 Apr; 9(3-4):358-67. PubMed ID: 25684126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles and Neurodegenerative Diseases.
    Hill AF
    J Neurosci; 2019 Nov; 39(47):9269-9273. PubMed ID: 31748282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of extracellular vesicles in neurodegenerative disorders.
    You Y; Ikezu T
    Neurobiol Dis; 2019 Oct; 130():104512. PubMed ID: 31229685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers.
    Thompson AG; Gray E; Heman-Ackah SM; Mäger I; Talbot K; Andaloussi SE; Wood MJ; Turner MR
    Nat Rev Neurol; 2016 Jun; 12(6):346-57. PubMed ID: 27174238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential of Liquid Biopsy of the Brain Using Blood Extracellular Vesicles: The First Step Toward Effective Neuroprotection Against Neurodegenerative Diseases.
    Abdel-Haq H
    Mol Diagn Ther; 2020 Dec; 24(6):703-713. PubMed ID: 32975732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipidomic Analysis of Plasma Extracellular Vesicles Derived from Alzheimer's Disease Patients.
    Krokidis MG; Pucha KA; Mustapic M; Exarchos TP; Vlamos P; Kapogiannis D
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in clinical trials for neurodegenerative diseases: regulatory perspectives and requirements.
    Broich K; Weiergräber M; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):498-500. PubMed ID: 21945642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer's Disease.
    Jiang L; Dong H; Cao H; Ji X; Luan S; Liu J
    Med Sci Monit; 2019 May; 25():3329-3335. PubMed ID: 31056537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications.
    Izadpanah M; Seddigh A; Ebrahimi Barough S; Fazeli SAS; Ai J
    J Mol Neurosci; 2018 Oct; 66(2):172-179. PubMed ID: 30140997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Role of Exosome in Neurodegenerative Diseases: A Review Study.
    Sheykhhasan M; Heidari F; Farsani ME; Azimzadeh M; Kalhor N; Ababzadeh S; Seyedebrahimi R
    Curr Stem Cell Res Ther; 2024; 19(6):852-864. PubMed ID: 37496136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia-derived extracellular vesicles in Alzheimer's Disease: A double-edged sword.
    Trotta T; Panaro MA; Cianciulli A; Mori G; Di Benedetto A; Porro C
    Biochem Pharmacol; 2018 Feb; 148():184-192. PubMed ID: 29305855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.